Mono Pharmacare Board of Directors

Get the latest insights into the leadership at Mono Pharmacare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Panilam Lakhatariya Managing Director
Mrs. Supal Panilam Lakhatariya Director
Mr. Archit Shah Director
Mr. Jitendra Mansukhlal Dasani Additional Director
Mr. Chinta Trivedi Independent Director

Mono Pharmacare Share price

MONOPHARMA

22.5

0.00 (0.00%)
NSE
BSE
Last updated on 4 Sep, 2025 | 09:07 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

22.10

52 Week High

41.95

The current prices are delayed, login to your account for live prices

Mono Pharmacare FAQs

The board at Mono Pharmacare consists of experienced professionals, including Mr. Panilam Lakhatariya , Mrs. Supal Panilam Lakhatariya , and others, overseeing the company’s strategic and corporate governance.

Directors at Mono Pharmacare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Panilam Lakhatariya is the current chairman at Mono Pharmacare.

Executive directors at Mono Pharmacare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Mono Pharmacare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Mono Pharmacare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.